TP53 and squamous cell carcinoma: Other clusters aligned with established categories: we observed a grouping of squamous cell carcinomas across different organs (esophagus, lung, head/neck; group 7) characterized by TP53 mutations and RTK/RAS pathway activation, as well as a clear cluster of renal cell tumors (group 8) distinguished by their unique metabolic and microenvironment profiles.